MSOS
AdvisorShares Pure US Cannabis ETF
Price Chart
Latest Quote
$4.46
| Previous Close | $4.36 |
| Open | $4.30 |
| Day High | $4.49 |
| Day Low | $4.29 |
| Volume | 3,041,067 |
Fund Information
| Net Assets | $1.05B |
| Expense Ratio | 0.78% |
| Category | Miscellaneous Sector |
| Fund Family | AdvisorShares |
| Net Asset Value | $4.47 |
| Premium/Discount | -0.29% |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $4.65 |
| SMA50 | $4.83 |
| SMA200 | $4.43 |
| RSI | 44.04 |
| ATR | 0.2534 |
| Rel Volume | 0.49 |
Performance History
| Week | -0.67% |
| Month | -7.66% |
| Quarter | +11.22% |
| 6 Months | -9.72% |
| YTD | -6.89% |
| Year | +76.98% |
| 3 Years | -25.04% |
| 5 Years | -88.96% |
| 10 Years | -81.87% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $4.46 | 3,054,600 |
| 2026-07-16 | $4.36 | 7,264,700 |
| 2026-07-15 | $4.56 | 3,975,500 |
| 2026-07-14 | $4.69 | 2,607,900 |
| 2026-07-13 | $4.70 | 6,528,000 |
| 2026-07-10 | $4.49 | 3,727,400 |
| 2026-07-09 | $4.46 | 4,746,800 |
| 2026-07-08 | $4.60 | 4,782,900 |
| 2026-07-07 | $4.55 | 4,363,500 |
| 2026-07-06 | $4.54 | 13,727,900 |
| 2026-07-02 | $4.89 | 4,302,900 |
| 2026-07-01 | $4.83 | 6,353,400 |
| 2026-06-30 | $5.08 | 9,250,100 |
| 2026-06-29 | $4.84 | 5,805,500 |
| 2026-06-26 | $4.69 | 4,457,700 |
| 2026-06-25 | $4.62 | 12,155,500 |
| 2026-06-24 | $4.43 | 5,457,600 |
| 2026-06-23 | $4.50 | 7,557,800 |
| 2026-06-22 | $4.68 | 7,821,300 |
| 2026-06-18 | $4.99 | 7,511,300 |
About AdvisorShares Pure US Cannabis ETF
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.
📰 Latest News
The Easiest Way to Bet on US Cannabis Is This One ETF
24/7 Wall St. • 2026-07-01T13:25:04Z
Cannabis’s 280E Tax Trap May Finally Break. We’ve Heard That Before.
24/7 Wall St. • 2026-06-30T14:45:50Z
Cannabis Stocks Pop As Another U.S. Company Applies to List on NYSE
Moby • 2026-06-18T20:20:56Z
Trulieve Makes History as the First US Cannabis Company to Trade on the NYSE
Moby • 2026-06-10T17:01:15Z
MSOS Hits 2026 High: Which Cannabis Stock Could Light Up Portfolios Ahead Of DEA Hearing?
Stocktwits • 2026-06-09T04:06:10Z
TLRY Stock Back Into The Limelight – A Look At The Key Developments That Sparked Investor Optimism
Stocktwits • 2026-06-05T14:04:53Z
Robinhood Is Opening the Door to U.S. Cannabis With Reform On the Horizon
Moby • 2026-05-29T20:39:56Z
US Reclassifies Weed: Can Cannabis ETFs Give Your Portfolio a New High?
Zacks • 2026-05-14T17:06:00Z
Cannabis Rescheduling Could Unlock the Biggest MSO Rally Since 2021
24/7 Wall St. • 2026-05-06T13:24:22Z
Uncle Sam Is Giving Big Pot a Tax Break. But It’s Complicated.
Moby • 2026-05-05T19:09:56Z